NCT00000553View on ClinicalTrials.gov

HDL-Atherosclerosis Treatment Study (HATS)

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

September 30, 1994

Study Completion Date

February 28, 2001

Conditions
Cardiovascular DiseasesCoronary DiseaseHeart DiseasesMyocardial Ischemia
Interventions
DRUG

simvastatin

DRUG

niacin

DRUG

antioxidants

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

University of Washington

OTHER

NCT00000553 - HDL-Atherosclerosis Treatment Study (HATS) | Biotech Hunter | Biotech Hunter